Trials / Conditions / SCID
SCID
6 registered clinical trials studyying SCID.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | Methadone as an Alternative Treatment for Children Underdoing HSCT NCT06940570 | University of Texas Southwestern Medical Center | Phase 3 |
| Active Not Recruiting | Conditioning SCID Infants Diagnosed Early NCT03619551 | Center for International Blood and Marrow Transplant Research | Phase 2 |
| Terminated | JSP191 Antibody Targeting Conditioning in SCID Patients NCT02963064 | Jasper Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | Participation in a Research Registry for Immune Disorders NCT01953016 | National Human Genome Research Institute (NHGRI) | — |
| Active Not Recruiting | Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies NCT01652092 | Masonic Cancer Center, University of Minnesota | N/A |
| Unknown | Patients Treated for SCID (1968-Present) NCT01346150 | National Institute of Allergy and Infectious Diseases (NIAID) | — |